JAGX
Price
$2.10
Change
-$0.12 (-5.41%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
4.02M
RNAZ
Price
$10.56
Change
-$0.55 (-4.95%)
Updated
Aug 7, 04:58 PM (EDT)
Capitalization
8.88M
Interact to see
Advertisement

JAGX vs RNAZ

Header iconJAGX vs RNAZ Comparison
Open Charts JAGX vs RNAZBanner chart's image
Jaguar Health
Price$2.10
Change-$0.12 (-5.41%)
Volume$381
Capitalization4.02M
TransCode Therapeutics
Price$10.56
Change-$0.55 (-4.95%)
Volume$100
Capitalization8.88M
JAGX vs RNAZ Comparison Chart in %
Loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAGX vs. RNAZ commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Buy and RNAZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (JAGX: $2.22 vs. RNAZ: $11.11)
Brand notoriety: JAGX and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 54% vs. RNAZ: 16%
Market capitalization -- JAGX: $4.26M vs. RNAZ: $8.88M
JAGX [@Biotechnology] is valued at $4.26M. RNAZ’s [@Biotechnology] market capitalization is $8.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, RNAZ is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 4 TA indicator(s) are bullish while RNAZ’s TA Score has 5 bullish TA indicator(s).

  • JAGX’s TA Score: 4 bullish, 2 bearish.
  • RNAZ’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, JAGX is a better buy in the short-term than RNAZ.

Price Growth

JAGX (@Biotechnology) experienced а +3.97% price change this week, while RNAZ (@Biotechnology) price change was -0.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAZ($8.88M) has a higher market cap than JAGX($4.02M). JAGX has higher P/E ratio than RNAZ: JAGX (0.01) vs RNAZ (0.00). RNAZ (-88.226) and JAGX (-91.188) have similar YTD gains . RNAZ has higher annual earnings (EBITDA): -25.05M vs. JAGX (-37.39M). RNAZ has more cash in the bank: 11.6M vs. JAGX (5.69M). RNAZ has less debt than JAGX: RNAZ (0) vs JAGX (38.3M). JAGX has higher revenues than RNAZ: JAGX (11.6M) vs RNAZ (0).
JAGXRNAZJAGX / RNAZ
Capitalization4.02M8.88M45%
EBITDA-37.39M-25.05M149%
Gain YTD-91.188-88.226103%
P/E Ratio0.010.00773%
Revenue11.6M0-
Total Cash5.69M11.6M49%
Total Debt38.3M0-
FUNDAMENTALS RATINGS
JAGX: Fundamental Ratings
JAGX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAGXRNAZ
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLX1.480.06
+4.23%
Protalix BioTherapeutics
XIFR8.97-0.09
-0.99%
XPLR Infrastructure LP
MCBS27.24-0.29
-1.05%
MetroCity Bankshares
TER104.88-2.05
-1.92%
Teradyne
SKK0.48-0.02
-4.48%
SKK Holdings Ltd

JAGX and

Correlation & Price change

A.I.dvisor tells us that JAGX and RNAZ have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JAGX and RNAZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
-0.22%
RNAZ - JAGX
31%
Poorly correlated
-3.39%
MRNA - JAGX
29%
Poorly correlated
-2.77%
CDIO - JAGX
29%
Poorly correlated
-1.01%
RXRX - JAGX
29%
Poorly correlated
-0.90%
DVHGF - JAGX
27%
Poorly correlated
N/A
More

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
-3.39%
NGNE - RNAZ
48%
Loosely correlated
-0.75%
ABCZF - RNAZ
37%
Loosely correlated
N/A
BPTSY - RNAZ
33%
Poorly correlated
N/A
AGEN - RNAZ
32%
Poorly correlated
-10.02%
JAGX - RNAZ
31%
Poorly correlated
-0.22%
More